Lucio Claudio Rovati

6 Patents

• US125443652026

  Pharmaceutical Combination of an EP4 Antagonist and Immune Checkpoint Inhibitors for the Treatment of Tumours

  Rottapharm Biotech S.R.L.

  0 cites
• US125094462025

  FYN and VEGFR2 Kinase Inhibitors

  Rottapharm Biotech S.R.L.

  0 cites
• US124338752025

  (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) Benzoic Acid or Its Salt Also in Polymorphic Form a for Use in the Prevention of Heterotopic Ossification

  Rottapharm Biotech S.R.L.

  0 cites
• US124042452025

  Process for the Preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) Benzoic Acid or a Salt Thereof

  Rottapharm Biotech S.R.L.

  0 cites
• US117185822023

  (r)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-benzoic Acid as EP4 Receptor Antagonist

  ROTTAPHARM BIOTECH S.R.L.

  0 cites
• US115901142023

  Pharmaceutical Combination of an EP4 Antagonist and Immune Checkpoint Inhibitors for the Treatment of Tumours

  ROTTAPHARM BIOTECH S.R.L.

  0 cites